SEC Form 4 · accession 0000911916-19-000032
ZIMMER BIOMET HOLDINGS, INC. · ZBH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Larry C Glasscock
Director
Period of report
Feb 8, 2019
Accepted (ET)
Feb 11, 2019 · 4:32 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001136869
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 8, 2019 | M | 3,092 | $43.73 | A | 6,593 | D | |
| Common StockF2 | Feb 8, 2019 | P | 2,000 | $120.091 | A | 8,593 | D | |
| Common StockF3 | holding | — | — | — | 40 | I | Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Employee Director Stock Option (right to buy) | $43.73 | Feb 8, 2019 | M | 3,092 | D | Dec 31, 2009 | May 3, 2019 | Common Stock | 3,092 | 0 | D |
Explanation of responses
- F1Includes 33 shares purchased under the dividend reinvestment plan for Zimmer Biomet Holdings, Inc.'s common stock between January 29, 2018 and January 31, 2019.
- F2Represents the purchase of 2,000 shares in multiple transactions ranging in price from $119.99 to $120.19 per share, resulting in a weighted average purchase price of $120.091. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each price within the range.
- F3Held in a trust with respect to which Mr. Glasscock shares voting authority with the trustee.